Microbiological Isolates Associated with Nosocomial Infections in Intensive Care Units: Data of 274 Intensive Care Units Participating in the German Nosocomial Infections Surveillance System (KISS);Erreger Nosokomialer Infektionen auf Intensivstationen: Daten des Krankenhaus-Infektions-Surveillance-Systems (KISS) aus 274 Intensivstationen

Anasthesiologie Intensivmedizin Notfallmedizin Schmerztherapie

Volumn 39, Issue 1, 2004, Pages 15-19

  Geffers, Christine ^a,b,c,e   Zuschneid, I ^a,b,c   Sohr, D ^a,b,c   Ruden H ^a,b,c   Gastmeler, P ^a,d  

^a Natl Ref Survlnc Nosokomialen I ^*  (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

^c FREIE UNIVERSITÄT BERLIN   (Germany)

^d HANNOVER MEDICAL SCHOOL   (Germany)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Bloodstream infection; Central line associated; MRSA; Nosocomial infections; Pathogen; Ventilator associated pneumonia

Indexed keywords

METICILLIN;

APPARATUS, EQUIPMENT AND SUPPLIES; ARTICLE; ARTIFICIAL VENTILATION; BACTERIUM ISOLATE; BRONCHITIS; CANDIDA ALBICANS; CATHETERIZATION; CENTRAL VENOUS CATHETER; CLINICAL TRIAL; COAGULASE NEGATIVE STAPHYLOCOCCUS; CROSS INFECTION; DATA BASE; DEMOGRAPHY; DEVICE INFECTION; ENTEROCOCCUS; ESCHERICHIA COLI; GERMAN NOSOCOMIAL INFECTIONS SURVEILLANCE SYSTEM; GERMANY; HEALTH SURVEY; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MULTICENTER STUDY; PENICILLIN RESISTANCE; PNEUMONIA; REGISTRATION; SEPSIS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; URINARY TRACT INFECTION;

CROSS INFECTION; EQUIPMENT AND SUPPLIES; GERMANY; HUMANS; INTENSIVE CARE UNITS; METHICILLIN RESISTANCE; POPULATION SURVEILLANCE; STAPHYLOCOCCAL INFECTIONS;

EID: 0842291569     PISSN: 09392661     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-815713     Document Type: Article

References (17)

1. Haley RW, Culver DH, White JW, Morgan WM, Emori TG, Munn VP, Hooton TM. The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. Am J Epidemiol 1985; 121: 182-205
2. Geffers C, Koch J, Sohr D, Nassauer A, Daschner F, Ruden H, Gastmeier P. Aufbau einer Referenzdatenbank für die Surveillance nosokomialer Infektionen auf Intensivstationen. Erste Ergebnisse des nationalen Krankenhaus-Infektions-Surveillance-Systems (KISS). Anaesthesist 2000; 49: 732-737
3. Emori TG, Culver DH, Horan TC, Jarvis WR, White JW, Olson DR, Banerjee S, Edwards JR, Martone WJ, Gaynes RP, et al. National nosocomial infections surveillance system (NNIS): description of surveillance methods. Am J Infect Control 1991; 19: 19-35
4. Garner J, Jarvis W, Emori T, Horan T, Hughes J. CDC definitions for nosocomial infections. APIC Infection Control and Applied Epidemiology: Principles and Practice. St. Louis: 1996
5. Anonymus. National Nosocomial Infections Surveillance (NNIS) report, data summary from October 1986 - April 1997, issued May 1997. A report from the NNIS System. Am J Infect Control, 1997; 25: 477-487
6. Vincent JL, Bihari DJ, Suter PM, Bruining HA, White J, Nicolas-Chanoin MH, Wolff M, Spencer RC, Hemmer M. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. Jama 1995; 274: 639-644
7. Fridkin SK, Welbel SF, Weinstein RA. Magnitude and prevention of nosocomial infections in the intensive care unit. Infect Dis Clin North Am 1997; 11: 479-496
8. Fridkin SK, Gaynes RP. Antimicrobial resistance in intensive care units. Clin Chest Med 1999; 20: 303-316; viii
9. Anonymus. National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1990-May 1999, issued June 1999. Am J Infect Control 1999; 27: 520-532
10. Anonymus. National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1992 - June 2002, issued August 2002. Am J Infect Control, 2002; 30: 458-475
11. Fridkin SK. Increasing prevalence of antimicrobial resistance in intensive care units. Crit Care Med 2001; 29: N64-N68
12. Paul-Ehrlich-Gesellschaft. Studie 2001: Arbeitsgemeinschaft "Empfindlichkeitsprüfung und Resistenz". 2003
13. Rello J, Sa-Borges M, Correa H, Leal SR, Baraibar J. Variations in etiology of ventilator-associated pneumonia across four treatment sites: implications for antimicrobial prescribing practices. Am J Respir Crit Care Med 1999; 160: 608-613
14. Rello J, Torres A. Microbial causes of ventilator-associated pneumonia. Semin Respir Infect 1996; 11: 24-31
15. Richards MJ, Edwards JR, Culver DH, Gaynes RP. Nosocomial infections in coronary care units in the United States. National Nosocomial Infections Surveillance System. Am J Cardiol 1998; 82: 789-793
16. Richards MJ, Edwards JR, Culver DH, Gaynes RP. Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit Care Med 1999; 27: 887-892
17. Richards MJ, Edwards JR, Culver DH, Gaynes RP. Nosocomial infections in pediatric intensive care units in the United States. National Nosocomial Infections Surveillance System. Pediatrics 1999; 103: e39